ANTIBODY TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d AND USE THEREOF
US-2016333082-A1 · Nov 17, 2016 · US
Bioactive peptides and methods of using same
US8987191B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8987191-B2 |
| Application number | US-201313923690-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 21, 2013 |
| Priority date | Jul 12, 2007 |
| Publication date | Mar 24, 2015 |
| Grant date | Mar 24, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed are peptide ligands for G-protein coupled receptors that are useful for treating disorders associated with G-protein coupled receptor activation.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of treating a fibrotic disorder or condition comprising administering to a subject in need thereof a peptide less than 35 amino acids in length, wherein said peptide comprises the amino acid sequence AYAAFSV (SEQ ID NO:2), and wherein the peptide is delivered for a time, frequency and amount effective to decrease the fibrotic disorder or condition in the subject. 2. The method of claim 1 , wherein said peptide comprises an a…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8987191B2 cover?
- Disclosed are peptide ligands for G-protein coupled receptors that are useful for treating disorders associated with G-protein coupled receptor activation.
- Who is the assignee on this patent?
- Compugen Ltd
- What technology area does this patent fall under?
- Primary CPC classification C07K14/472. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).